Cilgavimab (AZD-1061; COV2-2130) is a human monoclonal antibody designed to neutralize SARS-CoV-2. When combined with Tixagevimab, it forms the monoclonal antibody cocktail AZD7442. Demonstrating protective efficacy in mouse models of SARS-CoV-2 infection, Cilgavimab targets specific viral epitopes, preventing the virus from entering and infecting healthy cells. This antibody is crucial for research focused on the mechanisms of viral neutralization and the development of therapeutic strategies against COVID-19.
Cilgavimab (AZD-1061; COV2-2130) is a human monoclonal antibody designed to neutralize SARS-CoV-2. When combined with Tixagevimab, it forms the monoclonal antibody cocktail AZD7442. Demonstrating protective efficacy in mouse models of SARS-CoV-2 infection, Cilgavimab targets specific viral epitopes, preventing the virus from entering and infecting healthy cells. This antibody is crucial for research focused on the mechanisms of viral neutralization and the development of therapeutic strategies against COVID-19.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula: